Advanced KRASG12C-mutated non-small cell lung cancer subjects who previosly progressed on at least one prior line of therapy research hub

K-SAB trial

The K-SAB trial is looking for new ways to treat a specific type of advanced lung cancer called KRASG12C-mutated non-small cell lung cancer. It's for people whose previous treatments haven't worked or who can't have certain other common treatments like immunotherapy or chemotherapy.